Staple-line bleeding reduction using a bioabsorbable reinforcement in day surgery stapled hemorrhoidopexy

ISRCTN ISRCTN33808948
DOI https://doi.org/10.1186/ISRCTN33808948
Secondary identifying numbers N/A
Submission date
19/02/2010
Registration date
03/03/2010
Last edited
03/03/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Antonio Brescia
Scientific

Via di Grottarossa 1035
Rome
00189
Italy

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet.
Scientific titleStaple-line bleeding reduction using a bioabsorbable reinforcement in day surgery stapled hemorrhoidopexy: a randomied controlled trial
Study objectivesTo demonstrate that the use of circular bioabsorbable staple-line reinforcement can reduce the intraoperative and the postoperative bleeding while performing a stapled hemorrhoidopexy.
Ethics approval(s)Local medical ethics committee of the University Sapienza of Rome did not consider approval necessary as this trial is comparing two techniques and devices already in general use.
Health condition(s) or problem(s) studiedSymptomatic II-III grade haemorrhoids and rectal mucosal prolapse
InterventionPatients treated in the Operative Unit of Day Surgery (Saint Andrew’s Hospital), were randomly assigned to stapled hemorrhoidopexy performed using
1. Group A: the stapler PPH33-01® (Ethicon Endo-Surgery, Inc. Cincinnati, OH) with a circular bioabsorbable staple-line reinforcement, seamguard BSG® (WL Gore & Associates, Flagstaff, AZ)
2. Group B: the more haemostatic stapler, PPH33-03® (Ethicon Endo-Surgery, Inc. Cincinnati, OH) only.

The total duration of follow up is 90 days. All patients receive proctological examinations on 15, 45 and 90 days post-operatively. Patients in group A also receive retroscopy on these days.
Intervention typeOther
Primary outcome measure1. Intraoperative staple-line bleeding (yes or no)
2. Postoperative staple-line bleeding
Secondary outcome measures1. Operative time (from the start to the end of anaesthesia)
2. Use of additional stitches for haemostasis
3. Postoperative pain and/or tenesmus, assessed by VAS (visual analogue scale) at 6 and 24 hours post-operatively
4. Patient satisfaction, assessed by questionnaire at day 45
Overall study start date01/09/2009
Completion date20/12/2009

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants70
Key inclusion criteria1. Patients with symptomatic II-III grade haemorrhoids and rectal mucosal prolapse
2. Adults aged ≤ 65, male or female
Key exclusion criteria1. Patients without day surgery eligibility criteria
2. Concomitant ano-rectal disease (fissure, fistula, abscess, inflammatory bowel disease, rectal cancer)
3. Altered coagulation
4. Receiving anticoagulant-antiaggregant therapy
Date of first enrolment01/09/2009
Date of final enrolment20/12/2009

Locations

Countries of recruitment

  • Italy

Study participating centre

Via di Grottarossa 1035
Rome
00189
Italy

Sponsor information

La Sapienza University of Rome (Italy)
University/education

Faculty of Medicine and Surgery
Via di Grottarossa 1035
Rome
00189
Italy

ROR logo "ROR" https://ror.org/02be6w209

Funders

Funder type

Hospital/treatment centre

University Sapienza of Rome (Italy) - 2nd Faculty of Medicine and Surgery, Saint Andrew’s Hospital, Operative Unit of Day Surgery

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan